The downregulation of CLDN11 by miR-99 is associated with HCC metastasis (51), while the downregulation of CLDN3 is believed to promote EMT through the Wnt-β-catenin signaling pathway. This evidence concerns the gene CLDN11 and hepatocellular carcinoma.